These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1115 related items for PubMed ID: 3495566

  • 1. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

  • 2. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL, Herberman RB, Olszowy MW, Cramer DV, Salup RR, Reynolds CW, Hiserodt JC.
    Cancer Res; 1988 Feb 15; 48(4):884-90. PubMed ID: 3257412
    [Abstract] [Full Text] [Related]

  • 3. Precursor phenotype of lymphokine-activated killer cells in the mouse.
    Salup RR, Mathieson BJ, Wiltrout RH.
    J Immunol; 1987 Jun 01; 138(11):3635-9. PubMed ID: 3108370
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells.
    Yang JC, Mulé JJ, Rosenberg SA.
    J Immunol; 1986 Jul 15; 137(2):715-22. PubMed ID: 2873187
    [Abstract] [Full Text] [Related]

  • 6. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ, Krosnick JA, Rosenberg SA.
    J Immunol; 1989 Jan 15; 142(2):726-33. PubMed ID: 2783444
    [Abstract] [Full Text] [Related]

  • 7. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA, Vujanovic NL, Herberman RB, Hiserodt JC.
    J Immunol; 1988 Apr 15; 140(8):2846-52. PubMed ID: 3258622
    [Abstract] [Full Text] [Related]

  • 8. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ, Kern DE, Schultz KR, Greenberg PD, Cheever MA.
    J Immunol; 1988 May 15; 140(10):3679-85. PubMed ID: 2896213
    [Abstract] [Full Text] [Related]

  • 9. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I, Komuta K, Hara H, Inoue T, Hosoe S, Ikeda T, Shirasaka T, Yokota S, Tanio Y, Masuno T.
    Cancer Res; 1988 Mar 01; 48(5):1173-9. PubMed ID: 3257715
    [Abstract] [Full Text] [Related]

  • 10. Induction of murine lymphokine-activated killer cells by recombinant IL-7.
    Lynch DH, Miller RE.
    J Immunol; 1990 Sep 15; 145(6):1983-90. PubMed ID: 1975262
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneity of long-term cultured activated killer cells induced by anti-T3 antibody.
    Yun YS, Hargrove ME, Ting CC.
    J Immunol; 1988 Aug 15; 141(4):1390-7. PubMed ID: 3260924
    [Abstract] [Full Text] [Related]

  • 12. Generation and characterization of purified adherent lymphokine-activated killer cells in mice.
    Gunji Y, Vujanovic NL, Hiserodt JC, Herberman RB, Gorelik E.
    J Immunol; 1989 Mar 01; 142(5):1748-54. PubMed ID: 2783950
    [Abstract] [Full Text] [Related]

  • 13. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
    Tilden AB, Itoh K, Balch CM.
    J Immunol; 1987 Feb 15; 138(4):1068-73. PubMed ID: 3100627
    [Abstract] [Full Text] [Related]

  • 14. Murine trophoblast can be killed by lymphokine-activated killer cells.
    Drake BL, Head JR.
    J Immunol; 1989 Jul 01; 143(1):9-14. PubMed ID: 2499634
    [Abstract] [Full Text] [Related]

  • 15. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD, Economou JS, Shau H, Golub SH.
    J Surg Res; 1993 Nov 01; 55(5):486-92. PubMed ID: 8231167
    [Abstract] [Full Text] [Related]

  • 16. Generation of lymphokine-activated killer cell activity from human thymocytes.
    Ramsdell FJ, Golub SH.
    J Immunol; 1987 Sep 01; 139(5):1446-53. PubMed ID: 2442246
    [Abstract] [Full Text] [Related]

  • 17. Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations.
    Ballas ZK, Rasmussen W.
    J Immunol; 1990 Jan 01; 144(1):386-95. PubMed ID: 2104892
    [Abstract] [Full Text] [Related]

  • 18. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
    Ronchese F, Collavo D, Zanovello P, Cerundolo V, Biasi G.
    Immunology; 1985 Feb 01; 54(2):265-74. PubMed ID: 2578429
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J, Wisniewski D, Gulati S, Welte K, Knowles R, Clarkson B.
    Nat Immun Cell Growth Regul; 1987 Feb 01; 6(3):129-40. PubMed ID: 3114621
    [Abstract] [Full Text] [Related]

  • 20. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
    Shiloni E, Eisenthal A, Sachs D, Rosenberg SA.
    J Immunol; 1987 Mar 15; 138(6):1992-8. PubMed ID: 3493293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.